Willingness to pay for medical treatments in chronic diseases: a multicountry survey of patients and physicians
Abstract
Aim: The objective was to investigate factors influencing patients’ willingness to pay (WTP) and physician’s views on the cost of therapy for two contrasted chronic diseases, chronic heart failure and psoriasis. Methods: A cross-sectional survey was conducted in ten developing countries, using a stated WTP contingent valuation method. Multivariate analyses were performed by linear regression. Results: Independent factors influencing patient WTP were income (+0.04 $PPP [purchasing power parity] in WTP per $PPP in monthly income; p < 0.001) and purchase of branded treatment for chronic heart failure therapy, and income, out-of-pocket treatment costs but also education level higher than secondary school (+115 $PPP in WTP comparatively to patients with none/primary school level; p = 0.008) for psoriasis therapy, suggesting the influence of sociopsychological factors in this disease. Conclusion: Disease-specific factors may affect WTP for treatment that should be accounted for to support effective public health programs in developing countries.
Formats available
You can view the full content in the following formats:
References
Papers of special note have been highlighted as: • of interest
1.
Tambor M, Pavlova M, Rechel B, Golinowska S, Sowada C, Groot W. Willingness to pay for publicly financed health care services in Central and Eastern Europe: evidence from six countries based on a contingent valuation method. Soc. Sci. Med. 116, 193–201 (2014).
2.
Breidert C, Hahsler M, Reutterer T. A review of methods for measuring willingness-to-pay. Innov. Market. 2(4), 8–32 (2006).
• Provides key background on mehods for measuring willingness to pay.
3.
Whitty JA, Lancsar E, Rixon K, Golenko X, Ratcliffe J. A systematic review of stated preference studies reporting public preferences for healthcare priority setting. Patient 7(4), 365–386 (2014).
4.
Lin PJ, Cangelosi MJ, Lee DW, Neumann PJ. Willingness to pay for diagnostic technologies: a review of the contingent valuation literature. Value Health 16(5), 797–805 (2013).
5.
Deogaonkar R, Hutubessy R, Van Der Putten I, Evers S, Jit M. Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. BMC Public Health 12, 878 (2012).
6.
Whitty JA, Stewart S, Carrington MJ et al. Patient preferences and willingness-to-pay for a home or clinic based program of chronic heart failure management: findings from the Which? trial. PLoS ONE 8(3), e58347 (2013).
7.
Delfino M, Jr., Holt EW, Taylor CR, Wittenberg E, Qureshi AA. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriasis: a pilot study. J. Am. Acad. Derm. 59(3), 439–447 (2008).
• Provides key information on quality of life and preferences of patients with psoriasis.
8.
Ademi Z, Pasupathi K, Liew D. Cost–effectiveness of eplerenone compared to usual care in patients with chronic heart failure and NYHA class II symptoms, an Australian perspective. Medicine 95(18), e3531 (2016).
9.
Beikert FC, Langenbruch AK, Radtke MA, Kornek T, Purwins S, Augustin M. Willingness to pay and quality of life in patients with atopic dermatitis. Arch. Dermatolog. Res. 306(3), 279–286 (2014).
10.
Bridges JF. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. Ap. Health Econ. Health Pol. 2(4), 213–224 (2003).
• Other overview of stated preference techniques in health economics.
11.
Foreit JR, Foreit KG. The reliability and validity of willingness to pay surveys for reproductive health pricing decisions in developing countries. Health Policy 63(1), 37–47 (2003).
12.
Fendrick AM, Chernew ME. Value-based insurance design: aligning incentives to bridge the divide between quality improvement and cost containment. Am. J. Manag. Care 12(Spec no.), SP5–SP10 (2006).
13.
Braithwaite R, Rosen AB. Linking cost sharing to value: an unrivaled yet unrealized public health opportunity. Ann. Intern. Med. 146(8), 602–605 (2007).
14.
Radtke MA, Schafer I, Gajur A, Langenbruch A, Augustin M. Willingness-to-pay and quality of life in patients with vitiligo. Brit. J. Dermatol. 161(1), 134–139 (2009).
15.
Greenberg D, Hammerman A, Vinker S, Shani A, Yermiahu Y, Neumann PJ. Which is more valuable, longer survival or better quality of life? Israeli oncologists' and family physicians’ attitudes toward the relative value of new cancer and congestive heart failure interventions. Value Health 16(5), 842–847 (2013).
• Provides key information on quality of life and preferences of patients with chronic health failure.
16.
Fonta WM, Ichoku HE, Kabubo-Mariara J. The effect of protest zeros on estimates of willingness to pay in healthcare contingent valuation analysis. Ap. Health Econ. Health Pol. 8(4), 225–237 (2010).
17.
Murphy JJ, Allen PG, Stevens TH, Weatherhead D. A Meta-analysis of hypothetical bias in stated preference valuation. Environ. Resource Econ. 30(3), 313–325 (2005).
Information & Authors
Information
Published In
Copyright
© 2019 Axios International.
History
Received: 8 October 2018
Accepted: 21 December 2018
Published online: 16 January 2019
Keywords:
Topics
Authors
Metrics & Citations
Metrics
Article Usage
Article usage data only available from February 2023. Historical article usage data, showing the number of article downloads, is available upon request.
Citations
How to Cite
Willingness to pay for medical treatments in chronic diseases: a multicountry survey of patients and physicians. (2019) Journal of Comparative Effectiveness Research. DOI: 10.2217/cer-2018-0106
Export citation
Select the citation format you wish to export for this article or chapter.
Citing Literature
- Maryam Karandish, Sulmaz Ghahramani, Fatemeh Mohammadi, Mohammad Sayari, Seyyed Hossein Owji, Najmeh Moradi, Willingness to Pay for a Service Package Solving the Problems of Patients With Cleft Lip and Palate Referred to the Cleft Lip and Palate Center, International Journal of Paediatric Dentistry, 10.1111/ipd.70059, (2025).
- Hien Thi Bich Tran, Viet Nhu Nguyen, Phuong Nhat Le, Trung Quang Vo, Hiep Thanh Nguyen, Due The Ong, Van Nu Hanh Pham, Thao Ho Dieu Nguyen, Nhi Pham Yen Le, Setting cost-effectiveness thresholds for health technologies in Vietnam: A WTP/QALY approach, Health Policy and Technology, 10.1016/j.hlpt.2024.100972, 14, 3, (100972), (2025).
- Alexander H. Gunn, Haider J. Warraich, Robert J. Mentz, Costs of care and financial hardship among patients with heart failure, American Heart Journal, 10.1016/j.ahj.2023.12.001, 269, (94-107), (2024).
- I. S. van Maurik, E. D. Bakker, A. A. J. M. van Unnik, H. M. Broulikova, M. D. Zwan, E. van de Giessen, J. Berkhof, F. H. Bouwman, J. E. Bosmans, W. M. van der Flier, How healthy participants value additional diagnostic testing with amyloid-PET in patients diagnosed with mild cognitive impairment — a bidding game experiment, Alzheimer's Research & Therapy, 10.1186/s13195-023-01346-y, 15, 1, (2023).
- Nurin Haniah Asmuni, Adina Najwa Kamarudin, Norazliani Md Lazam, Hafizah Besar Sa'aid, Willingness to pay for heart disease insurance: A case study of a university hospital in Malaysia, The 5TH ISM INTERNATIONAL STATISTICAL CONFERENCE 2021 (ISM-V): Statistics in the Spotlight: Navigating the New Norm, 10.1063/5.0110694, (020018), (2023).
- Caroline Steigenberger, Magdalena Flatscher-Thoeni, Uwe Siebert, Andrea M. Leiter, Determinants of willingness to pay for health services: a systematic review of contingent valuation studies, The European Journal of Health Economics, 10.1007/s10198-022-01437-x, 23, 9, (1455-1482), (2022).
- Theodoros V. Giannouchos, Benjamin Ukert, Athanassios Vozikis, Evangelia Steletou, Kyriakos Souliotis, Informal out-of-pocket payments experience and individuals’ willingness-to-pay for healthcare services in Greece, Health Policy, 10.1016/j.healthpol.2021.04.001, 125, 6, (693-700), (2021).
- N. Poudel, B. Banjara, S. Kamau, N. Frost, S. Ngorsuraches, Factors influencing patients’ willingness-to-pay for disease-modifying therapies for multiple sclerosis, Multiple Sclerosis and Related Disorders, 10.1016/j.msard.2020.102720, 48, (102720), (2021).
- V. Boima, K. Agyabeng, V. Ganu, D. Dey, E. Yorke, M. B. Amissah-Arthur, A. A. Wilson, A. E. Yawson, C. C. Mate-Kole, J. Nonvignon, Willingness to pay for kidney transplantation among chronic kidney disease patients in Ghana, PLOS ONE, 10.1371/journal.pone.0244437, 15, 12, (e0244437), (2020).